Subscribe

Jennifer Fillman, MBA

Articles by Jennifer Fillman, MBA

CAR-T Cells: The Next Era in Immuno-Oncology

ByBruce A. Feinberg, DO,Jennifer Fillman, MBA,Justin Simoncini, MBA, MPH,Chadi Nabhan, MD, MBA, FACP

February 14th 2017

An update on immunotherapies and the potential impact of chimeric antigen receptor (CAR)-T cells on oncology care.

Latest Updated Articles

CAR-T Cells: The Next Era in Immuno-Oncology
Published: February 14th 2017 | Updated:

Trending on CGTlive®

Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial

Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years

Guess the Therapy Answer October 16, 2025

CGTLive®’s Weekly Rewind – October 17, 2025

© 2025 MJH Life Sciences^®

All rights reserved.